The Gonococcus fights back: is this time a knock out?

Sexually Transmitted Infections
David A Lewis

Abstract

Since the introduction of antibiotics in the 1930s, Neisseria gonorrhoeae has exhibited a remarkable ability to acquire novel genetic resistance determinants. Initially, sulphonamides were replaced by penicillin, while tetracyclines were prescribed for penicillin-allergic patients. With the advent of penicillinase-producing gonococci, spectinomycin was only briefly useful as alternative treatment and plasmid-mediated tetracycline resistance spread rapidly from the mid-1980s onwards. The fluoroquinolones followed but chromosomally mediated resistance appeared after only a decade of use. Seventy years on, we now face a global public health challenge of immense significance--the emergence of resistance to cephalosporins. With lack of investment in the search for new anti-gonococcal antimicrobial agents or vaccine research, the global spread of multiresistant gonococci can be seen. The impact of untreatable gonorrhoea on HIV transmission could be enormous in high-prevalence countries. This threat comes at a time when many national STI control programmes are weak. To delay the emergence of extensively drug-resistant gonorrhoea, public health systems require strengthening and novel strategies need implementing to enhance the therapeu...Continue Reading

Citations

Oct 1, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S O HjelmevollV Skogen
Jan 28, 2014·The Lancet Infectious Diseases·Makoto Ohnishi, Magnus Unemo
Apr 12, 2012·The Journal of Infectious Diseases·Jo-Anne R Dillon, Rajinder P Parti
Dec 22, 2010·The Journal of Antimicrobial Chemotherapy·Stephanie A ChisholmCatherine A Ison
May 19, 2012·The Journal of Antimicrobial Chemotherapy·David M WhileyTheo P Sloots
Jan 11, 2012·Antimicrobial Agents and Chemotherapy·Jan van de KassteeleAlbert J de Neeling
Jan 5, 2012·Antimicrobial Agents and Chemotherapy·Alexandra Dubon MercanteWilliam M Shafer
Sep 29, 2011·Infection and Immunity·Aimee HollanderCynthia Nau Cornelissen
Nov 28, 2013·Sexually Transmitted Infections·Monica M LahraDavid M Whiley
Jul 26, 2012·Future Microbiology·Holly B BratcherMartin C J Maiden
Dec 13, 2012·Future Microbiology·Magnus Unemo, Robert A Nicholas
Aug 12, 2014·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·D GolparianM Unemo
Aug 28, 2014·Der Urologe. Ausg. A·P Schneede, W Weidner
Feb 25, 2014·Clinics in Dermatology·Mihael Skerlev, Ivana Čulav-Košćak
Aug 20, 2011·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Magnus UnemoUNKNOWN Eastern European Sexual and Reproductive Health (EE SRH) Network Antimicrobial Resistance Group
Jan 14, 2012·Annals of the New York Academy of Sciences·Magnus Unemo, William M Shafer
Jul 14, 2011·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Slavyana GlazkovaMagnus Unemo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.